Biotechnology
The Biotechnology industry has a total of 592 stocks, with a combined market cap of $1.15 trillion and total revenue of $111.91 billion.
Market Cap
1.15T
Revenue
111.91B
Profits
-38.93B
PE Ratio
n/a
Profit Margin
-34.79%
Dividend Yield
0.04%
592 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 107.87B | -1.28% | 1,906,344 | 12.22B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 71.45B | -0.98% | 642,800 | 14.92B |
| 3 | ARGX | argenx SE | 49.39B | -2.02% | 248,165 | 4.24B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 40.20B | 1.07% | 823,895 | 4.29B |
| 5 | ONC | BeOne Medicines AG | 33.06B | 0.12% | 175,754 | 5.74B |
| 6 | RVMD | Revolution Medicines, Inc. | 31.30B | -0.47% | 3,321,768 | - |
| 7 | INSM | Insmed Incorporated | 30.10B | -0.41% | 1,238,325 | 606.42M |
| 8 | RPRX | Royalty Pharma plc | 29.90B | 0.48% | 4,722,958 | 2.38B |
| 9 | BNTX | BioNTech SE | 24.15B | -3.88% | 1,512,640 | 3.23B |
| 10 | ROIV | Roivant Sciences Ltd. | 20.27B | -0.14% | 2,646,031 | 13.31M |
| 11 | INCY | Incyte Corporation | 19.47B | 0.34% | 1,038,437 | 5.36B |
| 12 | MRNA | Moderna, Inc. | 18.53B | -1.25% | 4,834,190 | 2.23B |
| 13 | GMAB | Genmab A/S | 16.69B | 1.78% | 1,179,949 | 3.72B |
| 14 | ASND | Ascendis Pharma A/S | 13.92B | -1.50% | 446,124 | 845.52M |
| 15 | SMMT | Summit Therapeutics Inc. | 13.61B | 3.30% | 4,486,969 | - |
| 16 | BBIO | BridgeBio Pharma, Inc. | 13.47B | -0.30% | 2,119,262 | 502.08M |
| 17 | JAZZ | Jazz Pharmaceuticals plc | 13.07B | 2.02% | 1,215,230 | 4.44B |
| 18 | IONS | Ionis Pharmaceuticals, Inc. | 12.44B | -0.27% | 850,248 | 1.06B |
| 19 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.53B | -3.12% | 331,161 | 958.40M |
| 20 | AXSM | Axsome Therapeutics, Inc. | 11.48B | -0.29% | 1,019,975 | 708.24M |
| 21 | EXEL | Exelixis, Inc. | 11.28B | 0.57% | 3,563,502 | 2.38B |
| 22 | ARWR | Arrowhead Pharmaceuticals, Inc. | 10.49B | -1.91% | 1,257,550 | 1.09B |
| 23 | BMRN | BioMarin Pharmaceutical Inc. | 10.29B | -4.00% | 3,823,281 | 3.24B |
| 24 | ABVX | ABIVAX Société Anonyme | 9.78B | 5.68% | 1,267,923 | 5.37M |
| 25 | CYTK | Cytokinetics, Incorporated | 9.59B | 16.71% | 18,079,521 | 105.82M |
| 26 | PRAX | Praxis Precision Medicines, Inc. | 9.28B | -1.28% | 514,627 | 7.46M |
| 27 | TECH | Bio-Techne Corporation | 8.87B | 3.54% | 2,989,127 | 1.22B |
| 28 | KRYS | Krystal Biotech, Inc. | 8.39B | -0.83% | 414,582 | 417.30M |
| 29 | PCVX | Vaxcyte, Inc. | 8.03B | -4.87% | 2,169,792 | - |
| 30 | NUVL | Nuvalent, Inc. | 7.98B | -1.12% | 612,539 | - |
| 31 | IBRX | ImmunityBio, Inc. | 7.83B | 2.02% | 9,510,284 | 113.29M |
| 32 | HALO | Halozyme Therapeutics, Inc. | 7.80B | 2.01% | 1,478,959 | 1.40B |
| 33 | CELC | Celcuity Inc. | 6.85B | -2.27% | 1,419,526 | - |
| 34 | KYMR | Kymera Therapeutics, Inc. | 6.80B | -1.05% | 459,709 | 51.48M |
| 35 | MIRM | Mirum Pharmaceuticals, Inc. | 6.45B | 0.02% | 1,176,546 | 521.31M |
| 36 | PTGX | Protagonist Therapeutics, Inc. | 6.33B | -0.31% | 398,044 | 74.06M |
| 37 | COGT | Cogent Biosciences, Inc. | 6.32B | 0.68% | 1,739,527 | - |
| 38 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.32B | 7.86% | 1,899,171 | 217.17M |
| 39 | APGE | Apogee Therapeutics, Inc. | 6.22B | -0.31% | 389,869 | - |
| 40 | CNTA | Centessa Pharmaceuticals plc | 6.14B | -0.08% | 736,556 | 15.00M |
| 41 | SYRE | Spyre Therapeutics, Inc. | 6.13B | 2.72% | 2,010,985 | - |
| 42 | TERN | Terns Pharmaceuticals, Inc. | 6.11B | 0.04% | 6,347,046 | - |
| 43 | BLTE | Belite Bio, Inc | 6.07B | -0.08% | 88,473 | - |
| 44 | CGON | CG Oncology, Inc. | 5.91B | -0.78% | 743,671 | 4.04M |
| 45 | IMVT | Immunovant, Inc. | 5.67B | -0.04% | 1,047,765 | - |
| 46 | SRRK | Scholar Rock Holding Corporation | 5.62B | 1.41% | 583,550 | - |
| 47 | XENE | Xenon Pharmaceuticals Inc. | 5.58B | 0.54% | 1,230,205 | 7.50M |
| 48 | CORT | Corcept Therapeutics Incorporated | 5.51B | -0.52% | 1,176,335 | 769.10M |
| 49 | PTCT | PTC Therapeutics, Inc. | 5.39B | -0.69% | 740,428 | 1.73B |
| 50 | CAI | Caris Life Sciences, Inc. | 5.36B | 1.39% | 1,874,523 | 812.03M |
| 51 | TGTX | TG Therapeutics, Inc. | 5.33B | 1.09% | 2,468,853 | 616.29M |
| 52 | LEGN | Legend Biotech Corporation | 5.27B | 7.58% | 6,591,266 | 1.03B |
| 53 | APLS | Apellis Pharmaceuticals, Inc. | 5.24B | - | 2,838,568 | 1.00B |
| 54 | CRSP | CRISPR Therapeutics AG | 5.05B | -2.24% | 3,102,096 | 4.10M |
| 55 | DNTH | Dianthus Therapeutics, Inc. | 4.91B | 1.01% | 343,810 | 1.34M |
| 56 | MANE | Veradermics, Incorporated | 4.73B | 9.06% | 1,066,122 | - |
| 57 | LGND | Ligand Pharmaceuticals Incorporated | 4.65B | 1.73% | 105,664 | 268.09M |
| 58 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.27B | -1.21% | 916,839 | 7.70M |
| 59 | TVTX | Travere Therapeutics, Inc. | 4.17B | -0.24% | 3,310,824 | 536.20M |
| 60 | ORKA | Oruka Therapeutics, Inc. | 4.13B | 3.75% | 2,035,949 | - |
| 61 | EWTX | Edgewise Therapeutics, Inc. | 4.09B | 20.86% | 5,050,603 | - |
| 62 | ACAD | ACADIA Pharmaceuticals Inc. | 3.83B | 0.72% | 1,030,988 | 1.07B |
| 63 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.77B | 6.63% | 2,825,030 | 588.99M |
| 64 | TLX | Telix Pharmaceuticals Limited | 3.71B | -0.99% | 89,957 | 803.79M |
| 65 | VKTX | Viking Therapeutics, Inc. | 3.64B | -1.42% | 1,974,007 | - |
| 66 | TNGX | Tango Therapeutics, Inc. | 3.49B | 6.56% | 2,224,330 | 62.38M |
| 67 | NAMS | NewAmsterdam Pharma Company N.V. | 3.43B | -0.03% | 887,387 | 22.50M |
| 68 | ALMS | Alumis Inc. | 3.32B | 3.49% | 997,303 | 24.05M |
| 69 | RCUS | Arcus Biosciences, Inc. | 3.27B | 0.04% | 1,150,853 | 236.00M |
| 70 | KLRA | Kailera Therapeutics, Inc. | 3.14B | -3.31% | 425,204 | - |
| 71 | ERAS | Erasca, Inc. | 3.10B | -1.48% | 4,441,951 | - |
| 72 | DNLI | Denali Therapeutics Inc. | 3.00B | 1.34% | 2,535,662 | - |
| 73 | ARQT | Arcutis Biotherapeutics, Inc. | 2.93B | -0.30% | 850,256 | 376.07M |
| 74 | GPCR | Structure Therapeutics Inc. | 2.92B | -4.51% | 765,245 | - |
| 75 | BEAM | Beam Therapeutics Inc. | 2.90B | -3.92% | 2,053,657 | 139.74M |
| 76 | DYN | Dyne Therapeutics, Inc. | 2.89B | -1.36% | 1,048,873 | - |
| 77 | NKTR | Nektar Therapeutics | 2.84B | -3.14% | 799,170 | 55.23M |
| 78 | TARS | Tarsus Pharmaceuticals, Inc. | 2.77B | 0.73% | 343,312 | 451.36M |
| 79 | SLNO | Soleno Therapeutics, Inc. | 2.74B | 0.04% | 1,472,257 | 190.41M |
| 80 | CLDX | Celldex Therapeutics, Inc. | 2.66B | 3.33% | 725,602 | 1.55M |
| 81 | KOD | Kodiak Sciences Inc. | 2.65B | 0.95% | 973,029 | - |
| 82 | IMNM | Immunome, Inc. | 2.62B | -0.94% | 638,956 | 6.94M |
| 83 | IRON | Disc Medicine, Inc. | 2.58B | -0.07% | 322,414 | - |
| 84 | ELVN | Enliven Therapeutics, Inc. | 2.53B | -0.07% | 448,283 | - |
| 85 | IDYA | IDEAYA Biosciences, Inc. | 2.53B | -0.35% | 646,367 | 225.27M |
| 86 | VERA | Vera Therapeutics, Inc. | 2.48B | -2.79% | 1,315,547 | - |
| 87 | RLAY | Relay Therapeutics, Inc. | 2.46B | -0.69% | 1,951,285 | 10.68M |
| 88 | RARE | Ultragenyx Pharmaceutical Inc. | 2.45B | 0.81% | 1,481,952 | 670.00M |
| 89 | DFTX | Definium Therapeutics, Inc. | 2.44B | 2.99% | 1,042,611 | - |
| 90 | MLYS | Mineralys Therapeutics, Inc. | 2.41B | -1.25% | 826,710 | - |
| 91 | ADMA | ADMA Biologics, Inc. | 2.38B | -0.58% | 6,503,833 | 510.17M |
| 92 | ZLAB | Zai Lab Limited | 2.36B | -1.13% | 228,260 | 460.16M |
| 93 | SRPT | Sarepta Therapeutics, Inc. | 2.30B | -1.13% | 2,191,319 | 2.20B |
| 94 | OCUL | Ocular Therapeutix, Inc. | 2.11B | -0.61% | 4,217,484 | 52.04M |
| 95 | AUPH | Aurinia Pharmaceuticals Inc. | 2.08B | 1.71% | 928,880 | 283.06M |
| 96 | TRVI | Trevi Therapeutics, Inc. | 2.06B | 1.95% | 1,020,412 | - |
| 97 | STOK | Stoke Therapeutics, Inc. | 2.05B | -3.57% | 337,473 | 184.42M |
| 98 | TYRA | Tyra Biosciences, Inc. | 2.02B | -3.44% | 503,511 | - |
| 99 | TSHA | Taysha Gene Therapies, Inc. | 1.99B | 4.52% | 2,248,675 | 9.77M |
| 100 | ANAB | AnaptysBio, Inc. | 1.99B | -0.72% | 472,613 | 234.60M |
| 101 | AAPG | Ascentage Pharma Group International | 1.98B | -0.54% | 537 | 82.08M |
| 102 | ZYME | Zymeworks Inc. | 1.97B | -0.37% | 412,700 | 105.97M |
| 103 | GENB | Generate Biomedicines, Inc. | 1.97B | 6.64% | 289,728 | 31.89M |
| 104 | PHVS | Pharvaris N.V. | 1.96B | - | 547,116 | - |
| 105 | MESO | Mesoblast Limited | 1.95B | -1.31% | 83,861 | 65.38M |
| 106 | VRDN | Viridian Therapeutics, Inc. | 1.93B | 33.36% | 16,131,409 | 70.92M |
| 107 | CAPR | Capricor Therapeutics, Inc. | 1.91B | -1.61% | 692,938 | 11.13M |
| 108 | GLPG | Galapagos NV | 1.88B | -0.25% | 75,950 | 1.31B |
| 109 | VCEL | Vericel Corporation | 1.87B | 0.88% | 482,359 | 276.26M |
| 110 | INBX | Inhibrx Biosciences, Inc. | 1.87B | 0.13% | 422,251 | 1.30M |
| 111 | HRMY | Harmony Biosciences Holdings, Inc. | 1.87B | -0.77% | 593,437 | 868.45M |
| 112 | NTLA | Intellia Therapeutics, Inc. | 1.86B | -4.04% | 4,882,346 | 67.67M |
| 113 | PVLA | Palvella Therapeutics, Inc. | 1.85B | 1.46% | 212,306 | - |
| 114 | SION | Sionna Therapeutics, Inc. | 1.85B | 1.29% | 321,341 | - |
| 115 | SNDX | Syndax Pharmaceuticals, Inc. | 1.78B | 0.70% | 1,601,927 | 217.17M |
| 116 | RXRX | Recursion Pharmaceuticals, Inc. | 1.78B | -4.26% | 13,484,742 | 66.41M |
| 117 | ARDX | Ardelyx, Inc. | 1.76B | -2.33% | 5,857,546 | 427.68M |
| 118 | NRIX | Nurix Therapeutics, Inc. | 1.72B | -1.95% | 1,323,024 | 71.78M |
| 119 | RAPP | Rapport Therapeutics, Inc. | 1.70B | 0.17% | 164,335 | - |
| 120 | NUVB | Nuvation Bio Inc. | 1.68B | 9.52% | 10,891,129 | 143.05M |
| 121 | INVA | Innoviva, Inc. | 1.68B | -1.48% | 620,607 | 411.33M |
| 122 | NBTX | Nanobiotix S.A. | 1.65B | 11.59% | 79,121 | 38.27M |
| 123 | OCS | Oculis Holding AG | 1.64B | -1.80% | 424,669 | 1.51M |
| 124 | IOVA | Iovance Biotherapeutics, Inc. | 1.64B | 3.38% | 18,350,287 | 263.50M |
| 125 | AGIO | Agios Pharmaceuticals, Inc. | 1.62B | -1.27% | 870,476 | 66.05M |
| 126 | VIR | Vir Biotechnology, Inc. | 1.61B | -1.67% | 1,038,418 | 68.56M |
| 127 | GLUE | Monte Rosa Therapeutics, Inc. | 1.55B | -1.12% | 556,921 | 123.67M |
| 128 | PGEN | Precigen, Inc. | 1.53B | 4.59% | 3,866,152 | 9.68M |
| 129 | BCAX | Bicara Therapeutics Inc. | 1.52B | 1.94% | 486,496 | - |
| 130 | DMRA | Damora Therapeutics, Inc. | 1.50B | -4.09% | 142,531 | - |
| 131 | MAZE | Maze Therapeutics, Inc. | 1.47B | -1.37% | 557,418 | 2.50M |
| 132 | IMTX | Immatics N.V. | 1.47B | -1.71% | 640,151 | 56.67M |
| 133 | ATAI | AtaiBeckley Inc. | 1.47B | -4.76% | 4,569,626 | 4.09M |
| 134 | IMCR | Immunocore Holdings plc | 1.47B | 1.12% | 253,007 | 400.02M |
| 135 | BHVN | Biohaven Ltd. | 1.46B | -4.24% | 3,939,594 | - |
| 136 | ABCL | AbCellera Biologics Inc. | 1.41B | 1.53% | 13,351,767 | 75.13M |
| 137 | MBX | MBX Biosciences, Inc. | 1.41B | 0.54% | 312,730 | - |
| 138 | WVE | Wave Life Sciences Ltd. | 1.38B | -3.88% | 3,222,025 | 71.80M |
| 139 | FTRE | Fortrea Holdings Inc. | 1.37B | 18.61% | 4,228,475 | 2.71B |
| 140 | KALV | KalVista Pharmaceuticals, Inc. | 1.37B | 0.19% | 5,317,356 | 73.62M |
| 141 | QURE | uniQure N.V. | 1.33B | 2.32% | 1,566,267 | 18.09M |
| 142 | NVAX | Novavax, Inc. | 1.33B | 0.87% | 3,629,481 | 1.12B |
| 143 | SVRA | Savara Inc. | 1.33B | -0.94% | 927,385 | - |
| 144 | CRVS | Corvus Pharmaceuticals, Inc. | 1.32B | -2.00% | 773,648 | - |
| 145 | GHRS | GH Research PLC | 1.32B | -1.89% | 135,308 | - |
| 146 | AVBP | ArriVent BioPharma, Inc. | 1.32B | -1.81% | 336,468 | - |
| 147 | OLMA | Olema Pharmaceuticals, Inc. | 1.28B | 0.07% | 673,515 | - |
| 148 | MPLT | MapLight Therapeutics, Inc. | 1.27B | -2.41% | 212,357 | - |
| 149 | JBIO | Jade Biosciences, Inc. | 1.25B | 3.02% | 295,587 | - |
| 150 | ZBIO | Zenas BioPharma, Inc. | 1.23B | -3.71% | 398,761 | 10.00M |
| 151 | MLTX | MoonLake Immunotherapeutics | 1.22B | -3.13% | 701,352 | - |
| 152 | DBVT | DBV Technologies S.A. | 1.19B | 0.10% | 249,104 | 5.74M |
| 153 | URGN | UroGen Pharma Ltd. | 1.16B | 2.32% | 759,374 | 109.79M |
| 154 | PHAR | Pharming Group N.V. | 1.16B | -1.34% | 2,171 | 376.13M |
| 155 | EYPT | EyePoint, Inc. | 1.15B | -0.72% | 727,383 | 31.37M |
| 156 | AVLN | Avalyn Pharma Inc. | 1.15B | -5.64% | 467,970 | - |
| 157 | IVA | Inventiva S.A. | 1.14B | 2.85% | 261,851 | 7.94M |
| 158 | COAG | Hemab Therapeutics Holdings, Inc. | 1.10B | -1.34% | 461,167 | - |
| 159 | SEPN | Septerna, Inc. | 1.08B | -2.78% | 298,691 | 45.95M |
| 160 | XERS | Xeris Biopharma Holdings, Inc. | 1.08B | -1.74% | 1,418,730 | 291.85M |
| 161 | AKTS | Aktis Oncology, Inc. | 1.07B | 2.32% | 151,401 | 6.50M |
| 162 | OMER | Omeros Corporation | 1.06B | -0.94% | 779,082 | - |
| 163 | GERN | Geron Corporation | 1.06B | 5.10% | 15,760,555 | 183.88M |
| 164 | PHAT | Phathom Pharmaceuticals, Inc. | 1.00B | -2.14% | 1,092,899 | 204.89M |
| 165 | MRVI | Maravai LifeSciences Holdings, Inc. | 993.99M | 1.58% | 1,134,213 | 185.74M |
| 166 | ORIC | ORIC Pharmaceuticals, Inc. | 990.66M | -0.62% | 2,027,500 | - |
| 167 | SANA | Sana Biotechnology, Inc. | 968.47M | 2.35% | 1,670,038 | - |
| 168 | XNCR | Xencor, Inc. | 952.54M | -3.82% | 697,431 | 125.58M |
| 169 | LBRX | LB Pharmaceuticals Inc | 942.85M | 3.30% | 125,879 | - |
| 170 | ANNX | Annexon, Inc. | 929.54M | 0.53% | 1,917,644 | - |
| 171 | CGEM | Cullinan Therapeutics, Inc. | 918.08M | -2.61% | 893,291 | - |
| 172 | MGTX | MeiraGTx Holdings plc | 902.43M | 0.52% | 480,409 | 81.39M |
| 173 | SLS | SELLAS Life Sciences Group, Inc. | 898.67M | -2.99% | 2,859,379 | - |
| 174 | SPRY | ARS Pharmaceuticals, Inc. | 896.65M | 2.27% | 1,528,441 | 84.28M |
| 175 | ANRO | Alto Neuroscience, Inc. | 892.09M | 1.03% | 292,945 | - |
| 176 | CTMX | CytomX Therapeutics, Inc. | 888.19M | -2.39% | 2,395,596 | 76.20M |
| 177 | MNKD | MannKind Corporation | 883.16M | 1.78% | 3,029,569 | 348.97M |
| 178 | ABSI | Absci Corporation | 872.06M | -0.18% | 5,699,254 | 2.80M |
| 179 | JANX | Janux Therapeutics, Inc. | 871.72M | -0.62% | 1,226,488 | 10.00M |
| 180 | EVMN | Evommune, Inc. | 870.20M | 2.24% | 801,463 | 13.00M |
| 181 | ABUS | Arbutus Biopharma Corporation | 866.53M | 0.23% | 499,350 | 14.08M |
| 182 | TBPH | Theravance Biopharma, Inc. | 861.48M | -1.06% | 263,399 | 107.46M |
| 183 | SPTX | Seaport Therapeutics, Inc. | 848.45M | -5.88% | 892,723 | - |
| 184 | VOR | Vor Biopharma Inc. | 840.96M | 5.51% | 678,065 | - |
| 185 | DSGN | Design Therapeutics, Inc. | 837.55M | 1.82% | 677,233 | - |
| 186 | DRUG | Bright Minds Biosciences Inc. | 827.43M | 3.56% | 178,607 | - |
| 187 | KURA | Kura Oncology, Inc. | 824.61M | 0.43% | 816,875 | 67.48M |
| 188 | SGP | SpyGlass Pharma, Inc. | 815.94M | - | 63,862 | - |
| 189 | RLMD | Relmada Therapeutics, Inc. | 770.93M | -0.81% | 719,372 | - |
| 190 | GYRE | Gyre Therapeutics, Inc. | 754.61M | -1.77% | 61,028 | 116.59M |
| 191 | ALLO | Allogene Therapeutics, Inc. | 746.43M | -3.98% | 5,831,796 | 22.00K |
| 192 | TRAX | First Tracks Biotherapeutics, Inc. | 736.33M | 3.11% | 342,599 | - |
| 193 | TENX | Tenax Therapeutics, Inc. | 735.39M | -6.23% | 416,819 | - |
| 194 | LXRX | Lexicon Pharmaceuticals, Inc. | 699.07M | 3.12% | 1,588,386 | 49.80M |
| 195 | SLDB | Solid Biosciences Inc. | 679.05M | -4.56% | 1,422,227 | - |
| 196 | ARVN | Arvinas, Inc. | 678.63M | -1.58% | 722,403 | 262.60M |
| 197 | CABA | Cabaletta Bio, Inc. | 676.66M | 8.36% | 9,273,168 | - |
| 198 | FBRX | Forte Biosciences, Inc. | 668.01M | -4.28% | 151,609 | - |
| 199 | ACRS | Aclaris Therapeutics, Inc. | 663.40M | 4.86% | 1,072,514 | 7.83M |
| 200 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 661.87M | -2.25% | 173,573 | - |
| 201 | DRTS | Alpha Tau Medical Ltd. | 650.39M | -1.86% | 759,966 | - |
| 202 | ZVRA | Zevra Therapeutics, Inc. | 627.21M | 5.57% | 989,259 | 106.47M |
| 203 | STRO | Sutro Biopharma, Inc. | 618.31M | -2.79% | 236,771 | 102.48M |
| 204 | AGMB | AgomAb Therapeutics NV | 615.60M | 3.22% | 100,647 | - |
| 205 | CRMD | CorMedix Inc. | 606.25M | -2.15% | 850,281 | 311.71M |
| 206 | PRTA | Prothena Corporation plc | 602.39M | 3.71% | 306,816 | 9.68M |
| 207 | CBIO | Crescent Biopharma, Inc. | 600.78M | 0.89% | 380,598 | 11.88M |
| 208 | PRME | Prime Medicine, Inc. | 600.52M | -2.31% | 2,686,744 | 4.63M |
| 209 | ANL | Adlai Nortye Ltd. | 597.20M | -0.27% | 223,494 | 5.00M |
| 210 | ALT | Altimmune, Inc. | 594.25M | 1.32% | 3,470,414 | 41.00K |
| 211 | PROK | ProKidney Corp. | 579.77M | 2.13% | 478,807 | 893.00K |
| 212 | TRDA | Entrada Therapeutics, Inc. | 575.45M | -0.25% | 402,116 | 25.42M |
| 213 | AURA | Aura Biosciences, Inc. | 571.38M | 6.59% | 5,880,829 | - |
| 214 | DNA | Ginkgo Bioworks Holdings, Inc. | 565.19M | -2.02% | 1,414,474 | 170.16M |
| 215 | CADL | Candel Therapeutics, Inc. | 561.80M | 1.86% | 2,706,143 | - |
| 216 | KYTX | Kyverna Therapeutics, Inc. | 557.48M | 2.33% | 749,514 | - |
| 217 | EIKN | Eikon Therapeutics, Inc. | 556.54M | 0.10% | 148,517 | - |
| 218 | TECX | Tectonic Therapeutic, Inc. | 553.39M | -0.98% | 96,718 | - |
| 219 | CLYM | Climb Bio, Inc. | 546.95M | 18.16% | 1,790,163 | - |
| 220 | MDXG | MiMedx Group, Inc. | 542.16M | 0.83% | 1,918,075 | 389.42M |
| 221 | CTNM | Contineum Therapeutics, Inc. | 537.27M | 1.70% | 134,189 | - |
| 222 | ENGN | enGene Therapeutics Inc. | 528.55M | 3.68% | 426,271 | - |
| 223 | VSTM | Verastem, Inc. | 523.54M | 0.17% | 1,077,655 | 30.91M |
| 224 | RIGL | Rigel Pharmaceuticals, Inc. | 519.10M | -4.91% | 467,037 | 299.77M |
| 225 | VALN | Valneva SE | 509.41M | 2.32% | 7,816 | 205.07M |
| 226 | IMMX | Immix Biopharma, Inc. | 506.80M | 0.84% | 901,087 | - |
| 227 | OCGN | Ocugen, Inc. | 504.39M | -19.46% | 29,509,835 | 4.47M |
| 228 | XOMA | XOMA Royalty Corporation | 496.41M | 1.51% | 196,901 | 52.15M |
| 229 | UPB | Upstream Bio, Inc. | 496.31M | -2.04% | 262,659 | 2.85M |
| 230 | FDMT | 4D Molecular Therapeutics, Inc. | 495.71M | 2.86% | 541,902 | 85.21M |
| 231 | STTK | Shattuck Labs, Inc. | 494.30M | -5.49% | 516,248 | 1.00M |
| 232 | ZURA | Zura Bio Limited | 491.48M | -2.63% | 510,329 | - |
| 233 | OVID | Ovid Therapeutics Inc. | 489.70M | -3.41% | 2,260,342 | 7.25M |
| 234 | LYEL | Lyell Immunopharma, Inc. | 481.12M | -0.48% | 51,870 | 36.00K |
| 235 | ADCT | ADC Therapeutics SA | 478.24M | 2.17% | 2,158,278 | 79.18M |
| 236 | SGMT | Sagimet Biosciences Inc. | 476.72M | -2.28% | 1,291,239 | - |
| 237 | RGNX | REGENXBIO Inc. | 475.91M | -1.81% | 436,647 | 170.44M |
| 238 | ASMB | Assembly Biosciences, Inc. | 469.63M | 6.22% | 534,656 | 72.30M |
| 239 | PRLD | Prelude Therapeutics Incorporated | 469.58M | -1.48% | 417,576 | 12.14M |
| 240 | FULC | Fulcrum Therapeutics, Inc. | 467.77M | - | 599,304 | 80.00M |
| 241 | NGNE | Neurogene Inc. | 451.92M | 2.55% | 143,304 | 925.00K |
| 242 | AVIR | Atea Pharmaceuticals, Inc. | 448.15M | -1.75% | 217,464 | - |
| 243 | EPRX | Eupraxia Pharmaceuticals Inc. | 446.33M | -2.02% | 193,074 | - |
| 244 | VNDA | Vanda Pharmaceuticals Inc. | 444.40M | -2.25% | 895,624 | 216.11M |
| 245 | LXEO | Lexeo Therapeutics, Inc. | 441.56M | 2.76% | 416,493 | - |
| 246 | AUTL | Autolus Therapeutics plc | 436.47M | 4.46% | 1,379,488 | 75.39M |
| 247 | AVTX | Avalo Therapeutics, Inc. | 434.38M | 18.00% | 4,660,396 | 59.00K |
| 248 | ENTA | Enanta Pharmaceuticals, Inc. | 420.20M | -0.41% | 271,712 | 66.98M |
| 249 | NMRA | Neumora Therapeutics, Inc. | 420.18M | -0.43% | 701,455 | - |
| 250 | BNTC | Benitec Biopharma Inc. | 417.91M | 0.16% | 157,257 | - |
| 251 | LRMR | Larimar Therapeutics, Inc. | 416.57M | -4.98% | 1,952,378 | - |
| 252 | PRTC | PureTech Health plc | 416.06M | -2.00% | 27,860 | 4.66M |
| 253 | IPSC | Century Therapeutics, Inc. | 413.01M | - | 450,171 | 109.16M |
| 254 | VTVT | vTv Therapeutics Inc. | 394.62M | -2.15% | 24,015 | 17.00K |
| 255 | IVVD | Invivyd, Inc. | 393.10M | -5.44% | 2,392,125 | 53.43M |
| 256 | NAGE | Niagen Bioscience, Inc. | 386.79M | -2.23% | 811,250 | 129.42M |
| 257 | RCKT | Rocket Pharmaceuticals, Inc. | 386.48M | -1.94% | 1,275,853 | - |
| 258 | XFOR | X4 Pharmaceuticals, Inc. | 381.86M | -0.24% | 278,146 | 35.11M |
| 259 | MNPR | Monopar Therapeutics Inc. | 380.65M | 4.10% | 94,502 | - |
| 260 | SRZN | Surrozen, Inc. | 374.93M | 1.78% | 95,295 | 3.48M |
| 261 | PBYI | Puma Biotechnology, Inc. | 373.94M | -2.39% | 416,399 | 228.37M |
| 262 | IRD | Opus Genetics, Inc. | 371.29M | -0.38% | 716,739 | 14.20M |
| 263 | LCTX | Lineage Cell Therapeutics, Inc. | 363.67M | 2.82% | 1,175,323 | 14.56M |
| 264 | NAUT | Nautilus Biotechnology, Inc. | 363.45M | -1.04% | 276,943 | - |
| 265 | YDES | YD Bio Limited | 362.15M | 2.59% | 6,513 | 510.36K |
| 266 | CMPX | Compass Therapeutics, Inc. | 351.17M | 0.52% | 7,685,851 | 850.00K |
| 267 | IMRX | Immuneering Corporation | 345.48M | -0.93% | 682,444 | - |
| 268 | ARMP | Armata Pharmaceuticals, Inc. | 343.47M | -4.97% | 87,369 | 4.90M |
| 269 | RZLT | Rezolute, Inc. | 341.74M | -0.30% | 1,375,270 | - |
| 270 | BCYC | Bicycle Therapeutics plc | 341.56M | -0.81% | 318,718 | 63.50M |
| 271 | SLN | Silence Therapeutics plc | 337.25M | -2.06% | 120,876 | 559.00K |
| 272 | DMAC | DiaMedica Therapeutics Inc. | 336.77M | 3.31% | 159,246 | - |
| 273 | ABEO | Abeona Therapeutics Inc. | 331.63M | -2.02% | 1,144,802 | 5.82M |
| 274 | PALI | Palisade Bio, Inc. | 329.83M | -7.51% | 4,625,838 | - |
| 275 | IKT | Inhibikase Therapeutics, Inc. | 328.97M | -0.52% | 446,510 | 1.00 |
| 276 | AVXL | Anavex Life Sciences Corp. | 311.38M | -1.47% | 480,400 | - |
| 277 | GLSI | Greenwich LifeSciences, Inc. | 308.96M | 1.46% | 123,473 | - |
| 278 | NGEN | NervGen Pharma Corp. | 305.11M | 3.01% | 185,537 | - |
| 279 | ACIU | AC Immune SA | 298.60M | -1.31% | 251,565 | 4.62M |
| 280 | EDIT | Editas Medicine, Inc. | 297.53M | 1.33% | 1,270,587 | 38.69M |
| 281 | TARA | Protara Therapeutics, Inc. | 292.60M | -0.73% | 490,544 | - |
| 282 | ZNTL | Zentalis Pharmaceuticals, Inc. | 290.11M | 2.25% | 697,590 | 26.87M |
| 283 | CCCC | C4 Therapeutics, Inc. | 289.81M | -2.14% | 1,194,469 | 35.95M |
| 284 | ELDN | Eledon Pharmaceuticals, Inc. | 287.15M | - | 729,888 | - |
| 285 | LENZ | LENZ Therapeutics, Inc. | 284.38M | -2.26% | 676,432 | 19.09M |
| 286 | ALEC | Alector, Inc. | 283.63M | 2.39% | 361,275 | 21.05M |
| 287 | CHRS | Coherus Oncology, Inc. | 276.05M | 3.47% | 874,839 | 42.17M |
| 288 | NBP | NovaBridge Biosciences | 275.24M | -0.83% | 1,162,558 | - |
| 289 | FATE | Fate Therapeutics, Inc. | 274.42M | 31.11% | 10,705,860 | 6.65M |
| 290 | NERV | Minerva Neurosciences, Inc. | 274.01M | -1.26% | 115,510 | - |
| 291 | FHTX | Foghorn Therapeutics Inc. | 272.37M | -0.85% | 89,514 | 30.91M |
| 292 | CLLS | Cellectis S.A. | 269.67M | 1.62% | 11,372 | 79.59M |
| 293 | NVCT | Nuvectis Pharma, Inc. | 268.66M | 9.22% | 194,370 | - |
| 294 | ARTV | Artiva Biotherapeutics, Inc. | 262.00M | -6.11% | 152,903 | 251.00K |
| 295 | HELP | Cybin Inc. | 261.19M | -1.32% | 497,736 | - |
| 296 | ALXO | ALX Oncology Holdings Inc. | 259.70M | 2.66% | 673,240 | - |
| 297 | SABS | SAB Biotherapeutics, Inc. | 258.61M | -0.27% | 363,835 | 114.70K |
| 298 | CGEN | Compugen Ltd. | 257.19M | 3.03% | 452,594 | 72.76M |
| 299 | CDXS | Codexis, Inc. | 249.89M | 9.56% | 1,723,154 | 70.39M |
| 300 | ACHV | Achieve Life Sciences, Inc. | 242.77M | 3.87% | 858,930 | - |
| 301 | SLGL | Sol-Gel Technologies Ltd. | 241.15M | -5.06% | 42,255 | 19.39M |
| 302 | ADAG | Adagene Inc. | 239.18M | -1.09% | 37,955 | 7.67M |
| 303 | ARCT | Arcturus Therapeutics Holdings Inc. | 239.04M | -1.87% | 443,611 | 82.03M |
| 304 | REPL | Replimune Group, Inc. | 236.98M | -5.28% | 7,635,507 | - |
| 305 | OBIO | Orchestra BioMed Holdings, Inc. | 234.67M | -0.25% | 191,388 | 33.48M |
| 306 | KROS | Keros Therapeutics, Inc. | 232.90M | 0.51% | 309,709 | 244.06M |
| 307 | VYGR | Voyager Therapeutics, Inc. | 232.44M | 0.52% | 362,327 | 40.37M |
| 308 | HRTX | Heron Therapeutics, Inc. | 232.03M | 0.82% | 1,740,738 | 154.90M |
| 309 | FENC | Fennec Pharmaceuticals Inc. | 231.67M | 1.05% | 77,230 | 44.64M |
| 310 | MIST | Milestone Pharmaceuticals Inc. | 230.58M | -0.79% | 1,317,563 | 1.55M |
| 311 | CNTX | Context Therapeutics Inc. | 224.19M | 6.09% | 598,015 | - |
| 312 | MDWD | MediWound Ltd. | 224.14M | 1.04% | 97,882 | 16.96M |
| 313 | NKTX | Nkarta, Inc. | 219.58M | 1.99% | 1,152,517 | - |
| 314 | RNAC | Cartesian Therapeutics, Inc. | 217.13M | 6.64% | 296,348 | 1.78M |
| 315 | PLYX | Polaryx Therapeutics, Inc. | 214.94M | -11.33% | 132,001 | - |
| 316 | KPTI | Karyopharm Therapeutics Inc. | 212.13M | 1.18% | 201,785 | 146.07M |
| 317 | CAMP | Camp4 Therapeutics Corporation | 206.66M | 3.11% | 86,945 | 3.50M |
| 318 | UNCY | Unicycive Therapeutics, Inc. | 203.92M | 1.25% | 973,714 | - |
| 319 | OABI | OmniAb, Inc. | 202.70M | -0.71% | 260,345 | 18.67M |
| 320 | RNA | Atrium Therapeutics, Inc. | 200.30M | 0.31% | 321,001 | 18.62M |
| 321 | HUMA | Humacyte, Inc. | 200.24M | -2.48% | 4,050,994 | 2.04M |
| 322 | MGNX | MacroGenics, Inc. | 200.21M | -1.56% | 621,586 | 149.50M |
| 323 | WHWK | Whitehawk Therapeutics, Inc. | 198.70M | 1.20% | 112,655 | 7.15M |
| 324 | ENLV | Enlivex Ltd. | 197.61M | -3.80% | 243,547 | - |
| 325 | ELTX | Elicio Therapeutics, Inc. | 194.81M | -1.67% | 93,491 | - |
| 326 | DTIL | Precision BioSciences, Inc. | 192.23M | -2.36% | 284,172 | 45.07M |
| 327 | TNXP | Tonix Pharmaceuticals Holding Corp. | 191.77M | 3.61% | 268,379 | 13.11M |
| 328 | CRBU | Caribou Biosciences, Inc. | 189.64M | 1.05% | 992,511 | 11.16M |
| 329 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 189.25M | 1.43% | 234,977 | - |
| 330 | CNTN | Canton Strategic Holdings, Inc. | 183.00M | 2.22% | 227,439 | - |
| 331 | OKUR | OnKure Therapeutics, Inc. | 182.59M | -1.74% | 95,207 | - |
| 332 | TLSA | Tiziana Life Sciences Ltd | 182.50M | 2.88% | 135,040 | - |
| 333 | ABOS | Acumen Pharmaceuticals, Inc. | 182.01M | 1.61% | 271,738 | - |
| 334 | KRRO | Korro Bio, Inc. | 181.58M | -3.38% | 111,567 | 6.39M |
| 335 | PRQR | ProQR Therapeutics N.V. | 171.74M | -0.61% | 410,459 | 19.19M |
| 336 | ANTX | AN2 Therapeutics, Inc. | 168.82M | -3.30% | 317,638 | - |
| 337 | BDTX | Black Diamond Therapeutics, Inc. | 164.42M | 6.30% | 865,963 | 70.00M |
| 338 | TNYA | Tenaya Therapeutics, Inc. | 163.68M | -4.52% | 2,926,509 | - |
| 339 | MOLN | Molecular Partners AG | 161.25M | -3.56% | 6,363 | 856.30K |
| 340 | ORMP | Oramed Pharmaceuticals Inc. | 160.98M | 1.27% | 137,620 | 2.00M |
| 341 | SPRB | Spruce Biosciences, Inc. | 160.35M | -0.05% | 32,489 | 697.00K |
| 342 | AGEN | Agenus Inc. | 160.12M | 3.73% | 877,075 | 114.20M |
| 343 | MENS | Jyong Biotech Ltd. | 159.18M | -1.90% | 101,476 | - |
| 344 | PLX | Protalix BioTherapeutics, Inc. | 157.92M | -7.98% | 1,927,445 | 52.74M |
| 345 | KZIA | Kazia Therapeutics Limited | 153.69M | 4.75% | 244,530 | 1.27M |
| 346 | IMUX | Immunic, Inc. | 153.41M | 6.21% | 274,397 | - |
| 347 | HURA | TuHURA Biosciences, Inc. | 147.50M | 8.41% | 611,764 | - |
| 348 | GALT | Galectin Therapeutics Inc. | 146.80M | -2.62% | 320,108 | - |
| 349 | IFRX | InflaRx N.V. | 142.42M | -7.51% | 1,206,345 | 34.44K |
| 350 | SPRO | Spero Therapeutics, Inc. | 140.12M | -3.20% | 506,928 | 66.80M |
| 351 | CNTB | Connect Biopharma Holdings Limited | 139.61M | -0.40% | 220,452 | 64.00K |
| 352 | ACOG | Alpha Cognition Inc. | 138.92M | 5.45% | 36,383 | 10.22M |
| 353 | ALPS | Alps Group Inc | 138.00M | -9.76% | 39,393 | 3.74M |
| 354 | EDSA | Edesa Biotech, Inc. | 137.33M | -4.07% | 299,849 | - |
| 355 | IPHA | Innate Pharma S.A. | 135.08M | -2.10% | 25,808 | 10.57M |
| 356 | PEPG | PepGen Inc. | 133.39M | 7.22% | 902,856 | - |
| 357 | EQ | Equillium, Inc. | 130.88M | -1.43% | 115,971 | 4.39M |
| 358 | NTHI | NeOnc Technologies Holdings, Inc. | 125.69M | 20.53% | 475,035 | 39.99K |
| 359 | VRCA | Verrica Pharmaceuticals Inc. | 123.00M | 12.58% | 59,230 | 35.58M |
| 360 | GNLX | Genelux Corporation | 122.91M | -2.81% | 71,473 | 8.00K |
| 361 | KLRS | Kalaris Therapeutics, Inc. | 121.86M | -4.16% | 109,556 | - |
| 362 | AARD | Aardvark Therapeutics, Inc. | 119.33M | 3.80% | 105,545 | - |
| 363 | CBUS | Cibus, Inc. | 117.48M | 3.36% | 470,145 | 3.64M |
| 364 | PYXS | Pyxis Oncology, Inc. | 114.98M | 3.98% | 1,098,763 | 13.86M |
| 365 | CUE | Cue Biopharma, Inc. | 113.74M | 17.05% | 638,052 | 27.47M |
| 366 | CGTX | Cognition Therapeutics, Inc. | 110.80M | -3.13% | 687,230 | - |
| 367 | TTRX | Turn Therapeutics Inc. | 110.22M | -0.27% | 10,125 | - |
| 368 | GUTS | Fractyl Health, Inc. | 110.09M | -4.57% | 1,805,877 | 3.00K |
| 369 | CRDF | Cardiff Oncology, Inc. | 110.08M | -2.42% | 825,798 | 593.00K |
| 370 | BMEA | Biomea Fusion, Inc. | 109.90M | 2.70% | 1,144,137 | - |
| 371 | ONCY | Oncolytics Biotech Inc. | 106.26M | -1.36% | 1,554,225 | - |
| 372 | VANI | Vivani Medical, Inc. | 105.81M | -6.72% | 242,929 | - |
| 373 | SEER | Seer, Inc. | 104.94M | -4.62% | 1,020,985 | 16.58M |
| 374 | KALA | KALA BIO, Inc. | 104.20M | 3.80% | 2,107,876 | - |
| 375 | ALDX | Aldeyra Therapeutics, Inc. | 103.75M | 6.17% | 1,046,286 | - |
| 376 | ANIX | Anixa Biosciences, Inc. | 100.58M | -1.96% | 135,272 | - |
| 377 | NRXP | NRx Pharmaceuticals, Inc. | 100.43M | 1.33% | 1,333,388 | 1.23M |
| 378 | NRXS | NeurAxis, Inc. | 99.98M | 4.70% | 442,974 | 3.57M |
| 379 | COYA | Coya Therapeutics, Inc. | 99.69M | -0.23% | 159,933 | 7.95M |
| 380 | PMN | ProMIS Neurosciences, Inc. | 99.14M | -0.14% | 42,764 | - |
| 381 | INO | Inovio Pharmaceuticals, Inc. | 93.41M | - | 1,519,556 | 65.34K |
| 382 | ACET | Adicet Bio, Inc. | 91.48M | 0.71% | 106,465 | - |
| 383 | LONA | LeonaBio, Inc. | 90.46M | 0.84% | 20,444 | - |
| 384 | RANI | Rani Therapeutics Holdings, Inc. | 88.22M | -5.18% | 714,203 | 1.63M |
| 385 | PYPD | PolyPid Ltd. | 85.87M | 0.45% | 31,837 | - |
| 386 | PTHS | Pelthos Therapeutics Inc. | 85.40M | 2.54% | 8,821 | 16.80M |
| 387 | MAIA | MAIA Biotechnology, Inc. | 84.33M | - | 411,182 | - |
| 388 | OKYO | OKYO Pharma Limited | 83.97M | -4.76% | 33,388 | - |
| 389 | EXOZ | eXoZymes, Inc. | 83.84M | -0.32% | 1,198 | -700.00 |
| 390 | CSBR | Champions Oncology, Inc. | 82.90M | 1.36% | 2,253 | 57.95M |
| 391 | ATYR | aTyr Pharma, Inc. | 82.58M | -0.08% | 750,199 | 190.00K |
| 392 | ACRV | Acrivon Therapeutics, Inc. | 80.59M | -4.15% | 531,155 | - |
| 393 | ICCC | ImmuCell Corporation | 80.43M | 1.95% | 15,717 | 27.64M |
| 394 | FBIO | Fortress Biotech, Inc. | 79.22M | 3.36% | 318,640 | 63.26M |
| 395 | GANX | Gain Therapeutics, Inc. | 78.99M | -1.58% | 467,891 | - |
| 396 | GOSS | Gossamer Bio, Inc. | 78.86M | -4.11% | 4,346,604 | 48.47M |
| 397 | ANVS | Annovis Bio, Inc. | 78.39M | -0.44% | 1,761,195 | - |
| 398 | ATHE | Alterity Therapeutics Limited | 78.21M | 0.22% | 12,424 | 4.43M |
| 399 | XBIT | XBiotech Inc. | 77.74M | - | 14,271 | - |
| 400 | RLYB | Rallybio Corporation | 75.54M | 1.13% | 505,608 | 858.00K |
| 401 | QTTB | Q32 Bio Inc. | 75.20M | 1.98% | 263,373 | 53.74M |
| 402 | PLRX | Pliant Therapeutics, Inc. | 74.92M | 1.68% | 241,188 | - |
| 403 | PMVP | PMV Pharmaceuticals, Inc. | 73.06M | -2.14% | 292,741 | - |
| 404 | ACTU | Actuate Therapeutics, Inc. | 72.79M | 4.07% | 38,988 | - |
| 405 | OSTX | OS Therapies Incorporated | 72.73M | 4.22% | 278,282 | - |
| 406 | TCRX | TScan Therapeutics, Inc. | 72.72M | -0.82% | 1,000,766 | 10.33M |
| 407 | MCRB | Seres Therapeutics, Inc. | 72.24M | -2.47% | 110,158 | 1.15M |
| 408 | MNOV | MediciNova, Inc. | 69.40M | 0.71% | 9,220 | 409.66K |
| 409 | IBO | Impact BioMedical Inc. | 69.33M | 1.20% | 57,230 | 32.00K |
| 410 | FLNA | Filana Therapeutics, Inc. | 66.66M | -1.43% | 611,877 | - |
| 411 | IMA | ImageneBio, Inc. | 65.21M | 1.92% | 33,742 | 800.00K |
| 412 | IMMP | Immutep Limited | 62.53M | -0.35% | 1,381,805 | 5.28M |
| 413 | HYFT | MindWalk Holdings Corp. | 62.08M | 0.81% | 167,261 | 20.70M |
| 414 | ESLA | Estrella Immunopharma, Inc. | 60.01M | -8.07% | 18,863 | - |
| 415 | BYSI | BeyondSpring Inc. | 59.21M | -4.64% | 26,356 | 1.88M |
| 416 | PDSB | PDS Biotechnology Corporation | 59.16M | 6.00% | 666,499 | - |
| 417 | IBIO | iBio, Inc. | 58.19M | 1.90% | 796,681 | 300.00K |
| 418 | CING | Cingulate Inc. | 57.91M | -5.14% | 435,214 | - |
| 419 | INKT | MiNK Therapeutics, Inc. | 57.31M | -0.52% | 15,633 | - |
| 420 | KZR | Kezar Life Sciences, Inc. | 54.23M | -0.68% | 50,113 | - |
| 421 | ENTX | Entera Bio Ltd. | 54.08M | 4.50% | 132,906 | 42.00K |
| 422 | HYPD | Hyperion DeFi, Inc. | 53.20M | 3.78% | 490,805 | 813.46K |
| 423 | TIL | Instil Bio, Inc. | 53.10M | -0.13% | 32,673 | - |
| 424 | MGX | Metagenomi Therapeutics, Inc. | 53.08M | - | 66,072 | 25.21M |
| 425 | LIXT | Lixte Biotechnology Holdings, Inc. | 52.11M | 36.32% | 213,738 | - |
| 426 | NTRB | Nutriband Inc. | 49.60M | 10.27% | 32,786 | 2.04M |
| 427 | RADX | Radiopharm Theranostics Limited | 48.43M | 2.00% | 32,340 | 10.86M |
| 428 | DWTX | Dogwood Therapeutics, Inc. | 48.10M | 2.13% | 44,058 | - |
| 429 | ATOS | Atossa Therapeutics, Inc. | 48.05M | -4.78% | 199,073 | - |
| 430 | DARE | Daré Bioscience, Inc. | 47.61M | 5.14% | 2,380,840 | 1.03M |
| 431 | TELO | Telomir Pharmaceuticals, Inc. | 45.73M | 0.76% | 106,810 | - |
| 432 | XLO | Xilio Therapeutics, Inc. | 44.58M | -7.44% | 78,926 | 43.77M |
| 433 | MREO | Mereo BioPharma Group plc | 44.48M | -2.93% | 775,977 | 500.00K |
| 434 | PSTV | Plus Therapeutics, Inc. | 42.68M | -1.27% | 103,110 | 5.21M |
| 435 | RNXT | RenovoRx, Inc. | 41.82M | 4.87% | 268,291 | 1.12M |
| 436 | LITS | Lite Strategy, Inc. | 41.45M | - | 153,130 | - |
| 437 | INMB | INmune Bio Inc. | 40.94M | 4.05% | 345,541 | 50.00K |
| 438 | ATRA | Atara Biotherapeutics, Inc. | 40.52M | -2.46% | 46,671 | 120.77M |
| 439 | ALGS | Aligos Therapeutics, Inc. | 39.29M | -1.40% | 80,488 | 2.19M |
| 440 | ATNM | Actinium Pharmaceuticals, Inc. | 39.28M | 5.00% | 132,129 | 90.00K |
| 441 | EVAX | Evaxion A/S | 36.70M | -3.72% | 19,671 | 7.53M |
| 442 | GRCE | Grace Therapeutics, Inc. | 36.05M | -1.27% | 297,534 | - |
| 443 | VERU | Veru Inc. | 35.47M | -1.78% | 66,967 | 16.89M |
| 444 | BOLD | Boundless Bio, Inc. | 35.18M | - | 85,511 | - |
| 445 | APLM | Apollomics, Inc. | 35.14M | -2.85% | 1,118 | 8.84M |
| 446 | SNSE | Sensei Biotherapeutics, Inc. | 34.66M | -3.15% | 23,731 | - |
| 447 | TVRD | Tvardi Therapeutics, Inc. | 34.62M | 4.24% | 41,123 | - |
| 448 | CRVO | CervoMed Inc. | 34.54M | 0.81% | 17,181 | 4.01M |
| 449 | PTN | Palatin Technologies, Inc. | 34.11M | -0.20% | 12,265 | 8.96M |
| 450 | NXTC | NextCure, Inc. | 33.62M | 4.48% | 17,819 | - |
| 451 | NRSN | NeuroSense Therapeutics Ltd. | 33.58M | 6.72% | 213,083 | - |
| 452 | PLUR | Pluri Inc. | 33.17M | -2.28% | 9,157 | 1.34M |
| 453 | HOWL | Werewolf Therapeutics, Inc. | 32.55M | -2.94% | 315,068 | 1.14M |
| 454 | IGC | IGC Pharma, Inc. | 31.83M | 0.37% | 348,002 | 1.11M |
| 455 | QNTM | Quantum BioPharma Ltd. | 31.56M | 3.08% | 244,081 | - |
| 456 | NNVC | NanoViricides, Inc. | 31.53M | -2.67% | 410,811 | - |
| 457 | TPST | Tempest Therapeutics, Inc. | 30.84M | 1.90% | 122,527 | - |
| 458 | SKYE | Skye Bioscience, Inc. | 30.81M | 0.83% | 107,945 | - |
| 459 | TVGN | Tevogen Bio Holdings Inc. | 30.69M | -0.54% | 12,959 | - |
| 460 | SNTI | Senti Biosciences Holdings, Inc. | 29.71M | 1.21% | 61,269 | 22.00K |
| 461 | LSTA | Lisata Therapeutics, Inc. | 29.54M | -2.39% | 21,704 | 170.00K |
| 462 | BCTX | BriaCell Therapeutics Corp. | 29.24M | -0.49% | 55,327 | - |
| 463 | NEUP | Neuphoria Therapeutics Inc. | 29.08M | 1.98% | 27,994 | 14.99M |
| 464 | KYNB | Kyntra Bio, Inc. | 28.74M | -1.39% | 5,919 | 6.44M |
| 465 | RNTX | Rein Therapeutics Inc. | 28.60M | - | 2,964,404 | - |
| 466 | DYAI | Dyadic International, Inc. | 28.06M | 2.54% | 20,848 | 3.09M |
| 467 | CELU | Celularity Inc. | 27.48M | -3.17% | 76,678 | 26.55M |
| 468 | JSPR | Jasper Therapeutics, Inc. | 27.05M | -1.98% | 193,879 | - |
| 469 | SER | Serina Therapeutics, Inc. | 26.82M | -5.26% | 54,435 | 130.00K |
| 470 | BRNS | Barinthus Biotherapeutics plc | 26.76M | 3.15% | 17,569 | 14.97M |
| 471 | PLRZ | Polyrizon Ltd. | 26.47M | -8.18% | 25,102 | - |
| 472 | ABVC | ABVC BioPharma, Inc. | 25.45M | -1.90% | 78,762 | 797.92K |
| 473 | OTLK | Outlook Therapeutics, Inc. | 25.29M | -7.92% | 5,352,865 | 205.70K |
| 474 | MRKR | Marker Therapeutics, Inc. | 25.18M | -3.21% | 102,946 | 3.55M |
| 475 | LGVN | Longeveron Inc. | 25.07M | -0.78% | 221,117 | 1.20M |
| 476 | LTRN | Lantern Pharma Inc. | 24.21M | -3.14% | 202,271 | - |
| 477 | VTGN | Vistagen Therapeutics, Inc. | 23.78M | -3.58% | 235,540 | 789.00K |
| 478 | AEON | AEON Biopharma, Inc. | 23.41M | -2.63% | 17,476 | - |
| 479 | CRIS | Curis, Inc. | 22.80M | -1.83% | 191,647 | 9.44M |
| 480 | VYNE | VYNE Therapeutics Inc. | 22.20M | 1.54% | 453,525 | 570.00K |
| 481 | XCUR | Exicure, Inc. | 21.67M | 4.62% | 19,570 | 500.00K |
| 482 | ALLR | Allarity Therapeutics, Inc. | 21.65M | 12.00% | 353,854 | 320.00K |
| 483 | KTTA | Pasithea Therapeutics Corp. | 21.20M | 0.40% | 453,566 | - |
| 484 | QNCX | Quince Therapeutics, Inc. | 20.05M | 0.82% | 1,105,674 | - |
| 485 | CVKD | Cadrenal Therapeutics, Inc. | 19.45M | -4.39% | 103,311 | - |
| 486 | COCP | Cocrystal Pharma, Inc. | 19.02M | 5.34% | 203,311 | - |
| 487 | LPCN | Lipocine Inc. | 18.70M | 1.75% | 94,939 | 1.98M |
| 488 | CTXR | Citius Pharmaceuticals, Inc. | 18.62M | -3.27% | 508,564 | 3.94M |
| 489 | ICU | SeaStar Medical Holding Corporation | 17.65M | 2.08% | 38,134 | 1.23M |
| 490 | TOVX | Theriva Biologics, Inc. | 17.44M | 0.11% | 2,491,902 | 300.00K |
| 491 | LEXX | Lexaria Bioscience Corp. | 17.18M | 3.20% | 82,414 | 368.00K |
| 492 | OSRH | OSR Holdings, Inc. | 17.16M | -10.76% | 2,911,755 | 2.91M |
| 493 | NCEL | NewcelX Ltd. | 16.36M | -5.03% | 40,564 | - |
| 494 | TRAW | Traws Pharma, Inc. | 16.05M | 4.64% | 58,391 | 2.79M |
| 495 | INAB | IN8bio, Inc. | 15.95M | 0.62% | 36,832 | - |
| 496 | GNTA | Genenta Science S.p.A. | 15.81M | -3.19% | 99,262 | - |
| 497 | GRDX | GridAI Technologies Corp. | 15.19M | 0.82% | 54,428 | - |
| 498 | HIND | Vyome Holdings, Inc. | 14.53M | -0.96% | 30,875 | 319.71K |
| 499 | BLRX | BioLineRx Ltd. | 14.21M | - | 9,653 | 1.18M |
| 500 | CVM | CEL-SCI Corporation | 14.08M | 2.96% | 670,259 | - |